Accès à distance ? S'identifier sur le proxy UCLouvain
Immunoscore clinical utility to identify good prognostic colon cancer stage II patients with high-risk clinico-pathological features for whom adjuvant treatment may be avoided.
Primary tabs
- Open access
- 71.02 K
| Document type | Communication à un colloque (Conference Paper) – Présentation orale avec comité de sélection, Abstract |
|---|---|
| Access type | Accès libre |
| Publication date | 2019 |
| Language | Anglais |
| Conference | "ASCO-GI : American society of clinical oncology - Gastrointestinal Cancers Symposium", (United States) San Francisco, CA (du 17/01/2019 au 19/01/2019) |
| Journal information | "Journal of Clinical Oncology" - Vol. 37, no.Suppl 4, p. 487 (2019) |
| Peer reviewed | yes |
| issn | 0732-183X |
| e-issn | 1527-7755 |
| Publisher | American Society of Clinical Oncology (ASCO) ((United States) Alexandria, VA) |
| Publication status | Publié |
| Affiliations |
UCL
- SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie UCL - (SLuc) Unité d'oncologie médicale |
| Keywords | Cancer Research ; Oncology |
| Links |
| Bibliographic reference | Galon, Jerome ; Hermitte, Fabienne ; Mlecnik, Bernhard ; Marliot, Florence ; Bifulco, Carlo Bruno ; et. al. Immunoscore clinical utility to identify good prognostic colon cancer stage II patients with high-risk clinico-pathological features for whom adjuvant treatment may be avoided..ASCO-GI : American society of clinical oncology - Gastrointestinal Cancers Symposium ((United States) San Francisco, CA, du 17/01/2019 au 19/01/2019). In: Journal of Clinical Oncology, Vol. 37, no.Suppl 4, p. 487 (2019) |
|---|---|
| Permanent URL | http://hdl.handle.net/2078.1/213103 |